Pricing Log in Create free account

Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Tenax Therapeutics, Inc. (TENX)

Corbus Pharmaceuticals Holdings, Inc. and Tenax Therapeutics, Inc. are both Biotechnology companies. Tenax Therapeutics, Inc. is the larger, with a market value of $61.0M against $55.3M — 1.1× the size. Tenax Therapeutics, Inc. grew revenue faster over the last twelve months: −70.8% against −73.7%. Across the 13 metrics below, Tenax Therapeutics, Inc. leads on 10 and Corbus Pharmaceuticals Holdings, Inc. on 3.

Valuation

Metric CRBP TENX Biotechnology median
P/E n/m n/m 10.26
P/S 36.05 242.52 9.18
P/B 0.54 0.73 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.37 0.50 0.65
EV/Sales (26.17) (100.35) 8.98
Earnings yield (216.43%) (90.24%) (34.89%)
Free cash flow yield (156.18%) (55.21%) (24.52%)

Profitability

Metric CRBP TENX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (95.58%) (59.80%) (50.12%)
Return on assets (80.85%) (57.02%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBP TENX Biotechnology median
Revenue growth (TTM) (73.69%) (70.77%) 6.26%
EPS growth (last fiscal year) (60.33%) (16.52%) 29.88%
Revenue growth, 5-year CAGR (14.34%) 0.79% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBP TENX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.71 15.07 4.89
Net debt to EBITDA 1.90 1.73 1.01

Dividend

Metric CRBP TENX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRBP TENX Biotechnology median
Market cap 55.32m 61.00m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack